Citius Pharmaceuticals Inc (CTXR)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

11 COMMERCE DRIVE CRANFORD, NJ 07016

Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.

Data as of 2021-06-13 09:58:45 -0400
Market Cap352.232 Million Shares Outstanding135.474 Million Avg 30-day Volume4.856 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-7.77 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.08169 52-week High/Low2.9 / 0.78 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -17.4374
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from CTXR instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 39 23 69.57% 10 (0.59%) 8 (0.46%) 25.0%
13F shares: 10.933 Million 1.813 Million 503.11% 2.712 Million 468.94 Thousand 478.39%
% Ownership 14.5864 3.2618 347.19% 3.6186 0.8438 328.85%
New Positions: 20 11 81.82% 3 6 -50.0%
Increased Positions 12 6 100.0% 5 1 400.0%
Closed Positions 3 5 -40.0% 1 1 0.0%
Reduced Positions 1
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CTXR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTXR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DUTIA SUREN G

  • Director
0 2021-02-16 3

SAFIR HOWARD

  • Director
0 2021-02-16 3

WEBB CAROL

  • Director
0 2021-02-16 3

KANE WILLIAM

  • Director
0 2021-02-16 3

HOLUKA EUGENE MYRON

  • Director
0 2021-02-16 3

HOLUBIAK MYRON Z PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
1,992,243 2020-10-06 1

MAZUR LEONARD L EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
10,255,343 2020-10-06 1

BARTUSHAK JAIME CHIEF FINANCIAL OFFICER

  • Officer
60,353 2020-10-06 1

CZUCZMAN MYRON CHIEF MEDICAL OFFICER

  • Officer
0 2020-07-14 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CITIUS PHARMACEUTICALS INC CTXR 2021-06-18 13:15:03 UTC -12.0889 12.1289 600000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-18 12:45:03 UTC -12.0889 12.1289 600000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 22:15:03 UTC -12.0889 12.1289 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 21:45:03 UTC -12.0766 12.1166 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 21:15:03 UTC -12.0766 12.1166 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 20:45:04 UTC -12.0766 12.1166 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 20:15:03 UTC -12.0766 12.1166 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 19:45:03 UTC -12.0766 12.1166 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 19:15:03 UTC -12.0766 12.1166 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 18:45:04 UTC -12.1269 12.1669 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 18:15:03 UTC -12.1269 12.1669 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 17:45:03 UTC -12.1269 12.1669 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 17:15:03 UTC -12.1269 12.1669 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 16:45:03 UTC -12.1749 12.2149 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 16:15:02 UTC -12.1749 12.2149 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 15:45:03 UTC -12.1749 12.2149 350000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 15:15:03 UTC -12.1749 12.2149 300000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 14:45:02 UTC -12.1772 12.2172 400000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 14:15:03 UTC -12.1772 12.2172 400000
CITIUS PHARMACEUTICALS INC CTXR 2021-06-17 13:45:03 UTC -12.1772 12.2172 400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CTXR -8000.0 shares, $-14240.0 2021-03-31 N-PORT

Elevate your investments